US Bill To Radically Overhaul Cosmetics Regulations Passes Senate HELP Committee
Executive Summary
One voice emerged from the committee markup session as a potential cosmetics industry ally. In his opening remarks, ranking member Richard Burr, R-NC, said, “I worry that we’re rewarding bad behavior. Is this the time to expand FDA authority in any space, including diagnostic tests, cosmetics, and dietary supplements?”
You may also be interested in...
‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms
Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.
US House Appropriators Seek Data On Fragrance Allergens In Cosmetics, ‘Balance’ In Sunscreen Regs
The House Appropriations Committee asks the US Food and Drug Administration to provide a report to Congress in two years on the resources it would need to develop a database for fragrance allergens used in cosmetics. The committee’s report accompanying FY2023 FDA funding legislation also touches on OTC sunscreen regulation, PFAS in cosmetics, skin-lightening ingredients, and more.
Senate Expands Infant Formula Safety, Supply Workload For FDA, Industry In User Fees Bill
HELP Committee passes five-year reauthorization of FDA drug, medical device and biosimilar user fees with separate provisions expanding agency’s authority to regulate infant formula manufacturing and marketing and establishing Office of Critical Foods in CFSAN.